Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese

Breadcrumb

  1. Home
  2. S. epidermidis for a healthy nasal microbiota
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. S. epidermidis for a healthy nasal microbiota

S. epidermidis for a healthy nasal microbiota

Infection
Otorhinolaryngology

Symbiosis with Staphylococcus epidermidis could be involved in the maturation of the nasal microbiota during adolescence and the fight against pathogens: this bacterium, protected by a biofilm, could induce production of antimicrobial peptides by the nasal epithelium.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail
Photo : S. epidermidis for a healthy nasal microbiota

About this article

Created 20 March 2020
Updated 06 October 2021

 

The microbiotas of human epithelia are subject to mucosal immune defense mechanisms and their microbial composition changes significantly in early life during development of the immune system. Their lack of maturation is associated with certain diseases, although the development mechanisms for a healthy microbiota remain poorly understood. The nasal system remains one of the least studied of the various epithelial sites, even though the nostrils can harbor pathogenic agents responsible for serious systemic respiratory infections, such as Staphylococcus aureus or Moraxella catarrhalis. This explains the importance of this study of the nasal microbiota in 467 healthy volunteers across 3 different age groups: 155 children (average age of 5 years), 171 young adults (average age of 19 years) and 141 elderly subjects (average age of 82 years) respectively chosen to represent age groups in which immune status is not yet developed, is mature or is declining.

A characteristic microbiota for each age group

Analysis of the six dominant microbial phyla found that the composition of human nasal microbiota changed significantly with age and that microbial diversity decreased on reaching adulthood. Although Moraxella was predominant in children, this species was almost absent in the other two age groups. The abundance of Staphylococcus was multiplied by a factor of 4.4 during transition to adulthood, to the extent of becoming the predominant species in young adults. The opportunistic pathogen Dolosigranulum pigrum, which can cause upper respiratory tract infections, nosocomial pneumonia and septicemia, decreased by a factor of 2.4 between childhood and early adulthood. Finally, in elderly subjects, the increase of Staphylococcus and decrease of Dolosigranulum observed in young adults were partially reversed.

The protective effect of S. epidermidis

Based on their results, the researchers also proposed a potential mechanism though which one specific species–Staphylococcus epidermidis–, working in tandem with the host’s immune system, could lead to the exclusion of nasal pathogens. S. epidermidis could stimulate the production by nasal keratinocytes of antimicrobial peptides which kill pathogenic bacteria while S. epidermidis is resistant to these peptides due to its biofilm. This mechanism of symbiotic interaction between a bacterium from the human nasal microbiota and the innate host defense could in this way contribute to the exclusion of pathogenic agents, stabilization of the microbiota, and could help the host’s immune system differentiate between pathogenic and commensal bacteria.

 

Sources

Liu Q, Liu Q, Meng H, et al. Staphylococcus epidermidis Contributes to Healthy Maturation of the Nasal Microbiome by Stimulating Antimicrobial Peptide Production. Cell Host Microbe. 2020 Jan 8;27(1):68-78.e5.

Tags
Immunity Staphylococcus epidermidis Antimicrobial peptides Immune system Staphylococcus aureus Nose

en_view en_sources

    Created 20 March 2020
    Updated 06 October 2021

    About this article

    To know more about this topic.

    Main topic

    Infection

    Medical practice

    Otorhinolaryngology

    Content type

    News

    Continue reading

    News

    Infographics to share with your patients!

    Download original graphic material to explain to your patients the role of the microbiota in their daily he...

    Find out more

    Microbial colonization as a determinant factor for health during the first 1000 days of life

    By Pr. Marie-Claire ArrietaDepartments of Physiology and ...

    Find out more
    16.12.2022

    Does the gut microbiota influence vaccine efficacy?

    Read the article
    Everything you need to know about Microbiota & Immunity
    15.09.2022

    Everything you need to know about Microbiota & Immunity

    Read the article
    23.11.2022

    Is gut dysbiosis a risk factor for HIV infection?

    Read the article
    Photo: Antibiotic resistance is a web of several problems (HCPs)
    02.11.2022

    Antibiotic resistance is a web of several problems

    Read the article

    Xpeer course: Detection, Prevention and Treatment of Gut Microbiome Dysbiosis

    Find out more

    Xpeer course: Health outcomes of drugs-gut microbiota interactions

    Find out more
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    23.01.2023

    Idiopathic urethritis in men: new infectious etiologies?

    Read the article

    Impact of beer and non alcoholic comsumption on the gut microbiota

    By Pr. Bernd SchnablDivision of Gastroenterology, San Diego Digestive Diseases Research Center (SDDRC), UC ...

    Find out more

    Skin Microbiota #17

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo